December 8, 2008 (London, Ontario) — In the decision as to whether to replace an implantable cardioverter defibrillator (ICD) that has become subject to a safety advisory, the guiding equation is more ...
Upgrading a patient from an existing permanent pacemaker or implantable cardioverter-defibrillator (ICD) to a cardiac resynchronization therapy (CRT) device can be successfully and safely done in the ...
An implantable cardioverter defibrillator (ICD) is a small device that your doctor can put into your chest to help regulate an irregular heart rhythm, or an arrhythmia. Although it’s smaller than a ...
The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
From 1993 to 2006, 481,976 sample records of primary PM implantation were identified, which corresponds to 2.4 million (95% confidence interval [CI]: 2.28–2.50 million) patients with primary PM ...
Biotronik, a leading manufacturer of cardiovascular medical technology, announced that the first patient has been enrolled in the BioCONTINUE clinical trial (Biotronik study to assess the CONTINUation ...
S-ICD defibrillator: implantable device shocks irregular heartbeats to return them to normal rhythm San Clemente-based Cameron Health Inc. last week cleared a regulatory hurdle on the way to its sale ...
According to a broad European study involving multiple medical institutes, patients with diabetes do not benefit from implantable cardioverter defibrillator (ICD) pacemakers. Current treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results